Invitrogen to Test Viropro's Cell-Development, Protein Technologies | GenomeWeb
NEW YORK (GenomeWeb News) — Invitrogen and Viropro have signed an R&D agreement in which Invitrogen will test protein-production techniques and cell-development technology developed by Viropro, Viropro said today.
Viropro, based in Montreal, also said the deal allows the company the opportunity to out-license the combined technology and make intellectual property deals with biotech companies looking to integrate the IP into their own research and production processes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.